VRTX
VRTX
NASDAQ · Biotechnology

Vertex Pharmaceuticals Inc

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$542.62
-4.41 (-0.81%)
As of Nov 12, 9:31 PM ET ·
Analyst Consensus
Strong Buy
39
Analysts
Very High
Coverage
Buy 32 82%
Hold 6 15%
Sell 1 3%
Price Target
Analyst Price Target -19.2% upside
Low Target $313.95
Average Target $438.34
High Target $454.41
Current Price $542.62
Current
$542.62
Target
$438.34
$313.95 $438.34 avg $454.41
Scenario Analysis
Bear Case
$313.95
-42.1%
Low target
Base Case
$438.34
-19.2%
Avg target
Bull Case
$454.41
+-16.3%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$568.67
-4.6% from high
52-Week Low
$406.67
+33.4% from low
50-Day SMA
$523.04
+3.7% vs SMA
200-Day SMA
$482.70
+12.4% vs SMA
RSI (14)
54.8
Neutral
Target vs 52W High
$438.34
-22.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -59.1%
GILD
Gilead Sciences Inc
 Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
 Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
 Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
 Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
 Strong Buy 31 94% $114.11 -35.3%